Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: 6IJ4CQY76O

Pharmacology

Action Mechanism of Action Reference
INHIBITOR ErbB-2/ErbB-3 heterodimer inhibitor Other PubMed Other Other PubMed
Primary Target
erb-b2 receptor tyrosine kinase 2
erb-b2 receptor tyrosine kinase 3

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297556
FDA SRS 6IJ4CQY76O
Guide to Pharmacology 8931